The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands
induced pluripotent stem cellreprogramminggenetic cardiovascular diseasehuman embryonic stem celldisease modeldrug testing
